Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009956128> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W3009956128 abstract "Background: In 80% of patients, COVID-19 presents as mild disease1,2. 20% of cases develop severe (13%) or critical (6%) illness. More severe forms of COVID-19 present as clinical severe acute respiratory syndrome, but include a T-predominant lymphopenia3, high circulating levels of proinflammatory cytokines and chemokines, accumulation of neutrophils and macrophages in lungs, and immune dysregulation including immunosuppression4. Methods: All major SARS-CoV-2 proteins were characterized using an amino acid residue variation analysis method. Results predict that most SARS-CoV-2 proteins are evolutionary constrained, with the exception of the spike (S) protein extended outer surface. Results were interpreted based on known SARS-like coronavirus virology and pathophysiology, with a focus on medical countermeasure development implications. Findings: Non-neutralizing antibodies to variable S domains may enable an alternative infection pathway via Fc receptor-mediated uptake. This may be a gating event for the immune response dysregulation observed in more severe COVID-19 disease. Prior studies involving vaccine candidates for FCoV5,6 SARS-CoV-17-10 and Middle East Respiratory Syndrome coronavirus (MERS-CoV) 11 demonstrate vaccination-induced antibody-dependent enhancement of disease (ADE), including infection of phagocytic antigen presenting cells (APC). T effector cells are believed to play an important role in controlling coronavirus infection; pan-T depletion is present in severe COVID-19 disease3 and may be accelerated by APC infection. Sequence and structural conservation of S motifs suggests that SARS and MERS vaccine ADE risks may foreshadow SARS-CoV-2 S-based vaccine risks. Autophagy inhibitors may reduce APC infection and T-cell depletion12 13. Amino acid residue variation analysis identifies multiple constrained domains suitable as T cell vaccine targets. Evolutionary constraints on proven antiviral drug targets present in SARS-CoV-1 and SARS-CoV-2 may reduce risk of developing antiviral drug escape mutants. Interpretation: Safety testing of COVID-19 S protein-based B cell vaccines in animal models is strongly encouraged prior to clinical trials to reduce risk of ADE upon virus exposure." @default.
- W3009956128 created "2020-03-13" @default.
- W3009956128 creator A5015224335 @default.
- W3009956128 creator A5023468724 @default.
- W3009956128 date "2020-03-08" @default.
- W3009956128 modified "2023-09-30" @default.
- W3009956128 title "Medical Countermeasures Analysis of 2019-nCoV and Vaccine Risks for Antibody-Dependent Enhancement (ADE)" @default.
- W3009956128 doi "https://doi.org/10.20944/preprints202003.0138.v1" @default.
- W3009956128 hasPublicationYear "2020" @default.
- W3009956128 type Work @default.
- W3009956128 sameAs 3009956128 @default.
- W3009956128 citedByCount "18" @default.
- W3009956128 countsByYear W30099561282020 @default.
- W3009956128 countsByYear W30099561282021 @default.
- W3009956128 countsByYear W30099561282022 @default.
- W3009956128 countsByYear W30099561282023 @default.
- W3009956128 crossrefType "posted-content" @default.
- W3009956128 hasAuthorship W3009956128A5015224335 @default.
- W3009956128 hasAuthorship W3009956128A5023468724 @default.
- W3009956128 hasBestOaLocation W30099561281 @default.
- W3009956128 hasConcept C13373296 @default.
- W3009956128 hasConcept C142724271 @default.
- W3009956128 hasConcept C147483822 @default.
- W3009956128 hasConcept C159047783 @default.
- W3009956128 hasConcept C159654299 @default.
- W3009956128 hasConcept C164027704 @default.
- W3009956128 hasConcept C203014093 @default.
- W3009956128 hasConcept C2776914184 @default.
- W3009956128 hasConcept C2777648638 @default.
- W3009956128 hasConcept C2779134260 @default.
- W3009956128 hasConcept C2780194698 @default.
- W3009956128 hasConcept C3008058167 @default.
- W3009956128 hasConcept C524204448 @default.
- W3009956128 hasConcept C71924100 @default.
- W3009956128 hasConcept C86803240 @default.
- W3009956128 hasConcept C8891405 @default.
- W3009956128 hasConceptScore W3009956128C13373296 @default.
- W3009956128 hasConceptScore W3009956128C142724271 @default.
- W3009956128 hasConceptScore W3009956128C147483822 @default.
- W3009956128 hasConceptScore W3009956128C159047783 @default.
- W3009956128 hasConceptScore W3009956128C159654299 @default.
- W3009956128 hasConceptScore W3009956128C164027704 @default.
- W3009956128 hasConceptScore W3009956128C203014093 @default.
- W3009956128 hasConceptScore W3009956128C2776914184 @default.
- W3009956128 hasConceptScore W3009956128C2777648638 @default.
- W3009956128 hasConceptScore W3009956128C2779134260 @default.
- W3009956128 hasConceptScore W3009956128C2780194698 @default.
- W3009956128 hasConceptScore W3009956128C3008058167 @default.
- W3009956128 hasConceptScore W3009956128C524204448 @default.
- W3009956128 hasConceptScore W3009956128C71924100 @default.
- W3009956128 hasConceptScore W3009956128C86803240 @default.
- W3009956128 hasConceptScore W3009956128C8891405 @default.
- W3009956128 hasLocation W30099561281 @default.
- W3009956128 hasOpenAccess W3009956128 @default.
- W3009956128 hasPrimaryLocation W30099561281 @default.
- W3009956128 hasRelatedWork W1484759019 @default.
- W3009956128 hasRelatedWork W2005666125 @default.
- W3009956128 hasRelatedWork W2040191638 @default.
- W3009956128 hasRelatedWork W2050374169 @default.
- W3009956128 hasRelatedWork W2092481568 @default.
- W3009956128 hasRelatedWork W2168966876 @default.
- W3009956128 hasRelatedWork W2220102944 @default.
- W3009956128 hasRelatedWork W2409441623 @default.
- W3009956128 hasRelatedWork W2738799901 @default.
- W3009956128 hasRelatedWork W2102532225 @default.
- W3009956128 isParatext "false" @default.
- W3009956128 isRetracted "false" @default.
- W3009956128 magId "3009956128" @default.
- W3009956128 workType "article" @default.